OpenAlex
PricingAboutJobs
Log inGet started
Work

Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease

HTML

Year: 2021
Type: article
Study design: Observational Study
Source: Digestive and Liver Disease
DOI: 10.1016/j.dld.2021.11.021
Authors: Fabio Salvatore Macaluso, Maria Cappello, Federica Crispino, Mauro Grova, Antonino Carlo Privitera, Giovita Piccillo, Antonio Magnano, Concetta Ferracane, Nunzio Belluardo, Emiliano Giangreco, Walter Fries, Anna Viola, Roberto Di Mitri, Filippo Mocciaro, Salvatore Camilleri, Serena Garufi, Sara Renna, Angelo Casà, Marcello Maida, Ambrogio Orlando
Institutions: Ospedale Vincenzo Cervello, University of Palermo, Ospedale Cannizzaro, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco", Ospedale Maria Vittoria, Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Language: English

Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, Meso Scale Diagnostics, Chiesi Farmaceutici, Takeda Pharmaceutical Company
OpenAlex ID: W4200000290
FWCI: 1.943
Cites: 18
Cited by: 15
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms